| scholarly article | Q13442814 |
| P356 | DOI | 10.1290/1071-2690(2002)038<0165:EANECL>2.0.CO;2 |
| P698 | PubMed publication ID | 12026165 |
| P2093 | author name string | Antonio Bellastella | |
| Daniela Pasquali | |||
| Donatella Tramontano | |||
| Paolo Chieffi | |||
| Stefania Staibano | |||
| Antonio A Sinisi | |||
| Annamaria Kisslinger | |||
| P2860 | cites work | Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions | Q24307776 |
| Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B | Q24309625 | ||
| Activation of Pyk2 by stress signals and coupling with JNK signaling pathway | Q24323778 | ||
| The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells | Q28262541 | ||
| The serial cultivation of human diploid cell strains | Q29547356 | ||
| Production of high-titer helper-free retroviruses by transient transfection | Q29547802 | ||
| Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression | Q32005910 | ||
| Prostate cancer: molecular biology of early progression to androgen independence. | Q33871581 | ||
| Neuroendocrine cells in tumour growth of the prostate | Q33871591 | ||
| Growth factors and epithelial-stromal interactions in prostate cancer development | Q33955332 | ||
| Molecular genetics of prostate cancer. | Q34052664 | ||
| Establishment and characterization of a human prostatic carcinoma cell line (PC-3) | Q34210915 | ||
| Isolation of a human prostate carcinoma cell line (DU 145) | Q34255312 | ||
| LNCaP model of human prostatic carcinoma. | Q34271140 | ||
| In vivo amplification of the androgen receptor gene and progression of human prostate cancer | Q34314274 | ||
| Long-term culture and functional characterization of follicular cells from adult normal human thyroids | Q35758453 | ||
| Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells | Q36292127 | ||
| Etiology and disease process of benign prostatic hyperplasia | Q38211704 | ||
| In vitro modelling of epithelial and stromal interactions in non-malignant and malignant prostates. | Q38274089 | ||
| Potentiation of the malignant phenotype of the undifferentiated ARO thyroid cell line by insertion of the bcl-2 gene | Q40948868 | ||
| Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor | Q40959138 | ||
| Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model | Q40971854 | ||
| Regulation of prostatic growth and function by peptide growth factors | Q40998070 | ||
| Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 3. Oncogenes, suppressor genes, and applications | Q41130442 | ||
| Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications Part 2. Tumorigenic cell lines | Q41142028 | ||
| Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines | Q41147722 | ||
| Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer | Q41344070 | ||
| Intrinsic and extrinsic factors controlling benign prostatic growth | Q41461643 | ||
| A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. | Q41615181 | ||
| Immortalization of Human Adult Normal Prostatic Epithelial Cells by Liposomes Containing Large T-SV40 Gene | Q41667803 | ||
| Growth factor involvement in progression of prostate cancer | Q41745741 | ||
| Differential Cytokeratin Expression in Normal, Hyperplastic and Malignant Epithelial Cells From Human Prostate | Q41757486 | ||
| Cells in various benign and malignant conditions of the human prostate express different antigenic phenotypes | Q42470311 | ||
| Comparison of marker protein expression in benign prostatic hyperplasia in vivo and in vitro | Q42484157 | ||
| Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy | Q42492179 | ||
| AGAR SUSPENSION CULTURE FOR THE SELECTIVE ASSAY OF CELLS TRANSFORMED BY POLYOMA VIRUS. | Q45096251 | ||
| Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status. | Q47740760 | ||
| Different expression patterns of somatostatin receptor subtypes in cultured epithelial cells from human normal prostate and prostate cancer | Q48652007 | ||
| Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells. | Q53845982 | ||
| Thyrotropin is a potent growth factor for normal human thyroid cells in primary culture | Q69815817 | ||
| Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture | Q71091871 | ||
| Inhibition of prostatic epithelial cell proliferation by a factor secreted specifically by prostatic stromal cells | Q72650936 | ||
| A simple method for the isolation and culture of epithelial and stromal cells from benign and neoplastic prostates | Q73426071 | ||
| Culture of prostate epithelial cells of the rhesus monkey on extracellular matrix substrate: influence of steroids and insulin-like growth factors | Q93925917 | ||
| P433 | issue | 3 | |
| P921 | main subject | cell line | Q21014462 |
| P304 | page(s) | 165-172 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | In Vitro Cellular & Developmental Biology - Animal | Q1524094 |
| P1476 | title | EPN: a novel epithelial cell line derived from human prostate tissue | |
| P478 | volume | 38 |
| Q98726999 | An update on microRNAs as potential novel therapeutic targets in testicular germ cell tumors |
| Q39568883 | Antitumor effects of carnertinib in castration resistant prostate cancer models: a comparative study with erlotinib |
| Q54977237 | Aurora B: A new promising therapeutic target in cancer. |
| Q49229100 | Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation. |
| Q37286593 | Convergent Effects of Resveratrol and PYK2 on Prostate Cells. |
| Q39507690 | Down-regulation of CK2 activity results in a decrease in the level of cdc25C phosphatase in different prostate cancer cell lines |
| Q38780934 | Effects of Resveratrol on p66Shc phosphorylation in cultured prostate cells |
| Q37721103 | Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 in Cancer Development and Tumor Angiogenesis. |
| Q64266568 | Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells |
| Q39800864 | Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2. |
| Q37577433 | Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways. |
| Q39644350 | Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β. |
| Q34992292 | Spontaneous immortalization of human dermal microvascular endothelial cells |
| Q36394882 | Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research |
| Q112929538 | EPN | described by source | P1343 |
Search more.